62 related articles for article (PubMed ID: 31310954)
1. An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer.
Zhang J; Qu Z; Yao H; Sun L; Harata-Lee Y; Cui J; Aung TN; Liu X; You R; Wang W; Hai L; Adelson DL; Lin L
Biomed Pharmacother; 2019 Oct; 118():109169. PubMed ID: 31310954
[TBL] [Abstract][Full Text] [Related]
2. Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma.
Zhou S; Deng M; Bian X; Shi J; Liang R; Tao M
Cell Mol Biol (Noisy-le-grand); 2024 Feb; 70(2):120-127. PubMed ID: 38430032
[TBL] [Abstract][Full Text] [Related]
3. MiR-450a-5p strengthens the drug sensitivity of gefitinib in glioma chemotherapy via regulating autophagy by targeting EGFR.
Liu Y; Yang L; Liao F; Wang W; Wang ZF
Oncogene; 2020 Sep; 39(39):6190-6202. PubMed ID: 32820249
[TBL] [Abstract][Full Text] [Related]
4. NRSN2 promotes non-small cell lung cancer cell growth through PI3K/Akt/mTOR pathway.
Zhang XY; Kuang JL; Yan CS; Tu XY; Zhao JH; Cheng XS; Ye XQ
Int J Clin Exp Pathol; 2015; 8(3):2574-81. PubMed ID: 26045763
[TBL] [Abstract][Full Text] [Related]
5. Integrative Analysis of Proteome and Ubiquitylome Reveals Unique Features of Lysosomal and Endocytic Pathways in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells.
Li W; Wang H; Yang Y; Zhao T; Zhang Z; Tian Y; Shi Z; Peng X; Li F; Feng Y; Zhang L; Jiang G; Zhang F
Proteomics; 2018 Aug; 18(15):e1700388. PubMed ID: 29901268
[TBL] [Abstract][Full Text] [Related]
6. Traditional Herbal Medicine: A Potential Therapeutic Approach for Adjuvant Treatment of Non-small Cell Lung Cancer in the Future.
Huang J; Li JX; Ma LR; Xu DH; Wang P; Li LQ; Yu LL; Li Y; Li RZ; Zhang H; Zheng YH; Tang L; Yan PY
Integr Cancer Ther; 2022; 21():15347354221144312. PubMed ID: 36567455
[TBL] [Abstract][Full Text] [Related]
7. USP24-i-101 targeting of USP24 activates autophagy to inhibit drug resistance acquired during cancer therapy.
Young MJ; Wang SA; Chen YC; Liu CY; Hsu KC; Tang SW; Tseng YL; Wang YC; Lin SM; Hung JJ
Cell Death Differ; 2024 May; 31(5):574-591. PubMed ID: 38491202
[TBL] [Abstract][Full Text] [Related]
8. Autophagy inhibition enhances Matrine derivative MASM induced apoptosis in cancer cells via a mechanism involving reactive oxygen species-mediated PI3K/Akt/mTOR and Erk/p38 signaling.
Zou Y; Sarem M; Xiang S; Hu H; Xu W; Shastri VP
BMC Cancer; 2019 Oct; 19(1):949. PubMed ID: 31615459
[TBL] [Abstract][Full Text] [Related]
9. Yiqi Chutan Tang Reduces Gefitinib-Induced Drug Resistance in Non-Small-Cell Lung Cancer by Targeting Apoptosis and Autophagy.
Zhang J; Sun L; Cui J; Wang J; Liu X; Aung TN; Qu Z; Chen Z; Adelson DL; Lin L
Cytometry A; 2020 Jan; 97(1):70-77. PubMed ID: 31411813
[TBL] [Abstract][Full Text] [Related]
10. Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology.
Zhou W; Wu J; Zhang J; Liu X; Guo S; Jia S; Zhang X; Zhu Y; Wang M
Sci Rep; 2020 Jul; 10(1):12745. PubMed ID: 32728182
[TBL] [Abstract][Full Text] [Related]
11. Compound kushen injection relieves tumor-associated macrophage-mediated immunosuppression through TNFR1 and sensitizes hepatocellular carcinoma to sorafenib.
Yang Y; Sun M; Yao W; Wang F; Li X; Wang W; Li J; Gao Z; Qiu L; You R; Yang C; Ba Q; Wang H
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32179631
[TBL] [Abstract][Full Text] [Related]
12. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
He R; Ou S; Chen S; Ding S
Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
[TBL] [Abstract][Full Text] [Related]
13. Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine.
Liang S; Li Y; Zhang X; Guo Y; Pan S
Anticancer Agents Med Chem; 2021; 21(15):2012-2022. PubMed ID: 33573576
[TBL] [Abstract][Full Text] [Related]
14. A Bioinformatics Research on Novel Mechanism of Compound Kushen Injection for Treating Breast Cancer by Network Pharmacology and Molecular Docking Verification.
Liu S; Hu X; Fan X; Jin R; Yang W; Geng Y; Wu J
Evid Based Complement Alternat Med; 2020; 2020():2758640. PubMed ID: 32849897
[TBL] [Abstract][Full Text] [Related]
15. Compound Kushen Injection as an Adjunctive Therapy for the Treatment of Non-Small-Cell Lung Cancer: A Meta-Analysis of Randomized Controlled Trials.
Pu L; Chen WH; Cao LX; Wu KJ; Chen SL; Lin JH; Li CL; Wang SQ; Zhu MM; Zhang YM
Evid Based Complement Alternat Med; 2019; 2019():7241927. PubMed ID: 31781277
[TBL] [Abstract][Full Text] [Related]
16. A New Strategy for Identifying Mechanisms of Drug-drug Interaction Using Transcriptome Analysis: Compound Kushen Injection as a Proof of Principle.
Shen H; Qu Z; Harata-Lee Y; Cui J; Aung TN; Wang W; Kortschak RD; Adelson DL
Sci Rep; 2019 Nov; 9(1):15889. PubMed ID: 31685921
[TBL] [Abstract][Full Text] [Related]
17. Fractional Deletion of Compound Kushen Injection Indicates Cytokine Signaling Pathways are Critical for its Perturbation of the Cell Cycle.
Aung TN; Nourmohammadi S; Qu Z; Harata-Lee Y; Cui J; Shen HY; Yool AJ; Pukala T; Du H; Kortschak RD; Wei W; Adelson DL
Sci Rep; 2019 Oct; 9(1):14200. PubMed ID: 31578346
[TBL] [Abstract][Full Text] [Related]
18. Bibliometric and visual analysis in the field of traditional Chinese medicine in cancer from 2002 to 2022.
Bai F; Huang Z; Luo J; Qiu Y; Huang S; Huang C; Liu T; Zhang H; Wang D
Front Pharmacol; 2023; 14():1164425. PubMed ID: 37469862
[No Abstract] [Full Text] [Related]
19. Evaluation of efficacy and safety for compound kushen injection combined with intraperitoneal chemotherapy for patients with malignant ascites: A systematic review and meta-analysis.
Yu HB; Hu JQ; Han BJ; Cao HJ; Chen ST; Chen X; Xiong HT; Gao J; Du YY; Zheng HG
Front Pharmacol; 2023; 14():1036043. PubMed ID: 36937874
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
